Taken together, our results demonstrated that MBC possessed potential protective effects against NAFLD in vitro by amelioration of lipid metabolism and inflammatory markers through the AMPK/NF-κB signaling pathway. The gene discussed is NFKB1; the disease is metabolic dysfunction-associated steatotic liver disease.